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nificantly more polymers and was a stronger promoter of cal-Nucleation of calcium oxalate crystals by albumin: Involvement
cium oxalate nucleation than albumin from idiopathic calciumin the prevention of stone formation.
stone formers.Background. Urine is supersaturated in calcium oxalate,
Conclusions. Promotion by albumin of calcium oxalate crys-which means that it will contain calcium oxalate crystals that
tallization with specific formation of the dihydrate form mightform spontaneously. Their size must be controlled to prevent
be protective, because with rapid nucleation of small crystals,retention in ducts and the eventual development of a lithiasis.
This is achieved, in part, by specific inhibitors of crystal growth. the saturation levels fall; thus, larger crystal formation and
We investigated whether promoters of crystal nucleation could aggregation with subsequent stone formation may be pre-
also participate in that control, because for the same amount vented. We believe that albumin may be an important factor
of salt that will precipitate from a supersaturated solution, of urine stability.
increasing the number of crystals will decrease their average
size and facilitate their elimination.
Methods. Albumin was purified from commercial sources
Calcium oxalate (CaOx) saturation in normal urineand from the urine of healthy subjects or idiopathic calcium
exceeds the limit of metastability, which explains whystone formers. Its aggregation properties were characterized
by biophysical and biochemical techniques. Albumin was then CaOx crystals are often found in urine, even in healthy
either attached to several supports or left free in solution and subjects (HS). Crystallogenesis is controlled so that crys-
incubated in a metastable solution of calcium oxalate. Kinetics
tals are kept small enough to be swept out by the urineof calcium oxalate crystallization were determined by turbidim-
flow. Perturbations in the control mechanism may resultetry. The nature and efficiency of nucleation were measured
by examining the type and number of neoformed crystals. in either the formation of large crystal aggregates or
Results. Albumin, one of the most abundant proteins in urine, crystal adhesion to tubular cells, thus leading to possible
was a powerful nucleator of calcium oxalate crystals in vitro, subsequent stone formation. The fact that all stones con-with the polymers being more active than monomers. In addi-
tained proteins [1, 2] focused the attention on their iden-tion, nucleation by albumin apparently led exclusively to the
tification. First, Boyce et al showed that a glycosylatedformation of calcium oxalate dihydrate crystals, whereas cal-
cium oxalate monohydrate crystals were formed in the absence mucoprotein, called matrix substance A, was present in
of albumin. An analysis of calcium oxalate crystals in urine all stones [3, 4]. Later, the heterogeneity of proteins
showed that the dihydrate form was present in healthy subjects
present within the stone matrix was established by sev-and stone formers, whereas the monohydrate, which is thermo-
eral researchers [5–8]. However, depending on the pro-dynamically more stable and constitutes the core of most cal-
cium oxalate stones, was present in stone formers only. Finally, cedures used in protein extraction and characterization,
urinary albumin purified from healthy subjects contained sig- various results were obtained on both qualitative and
quantitative levels [8–10]. Furthermore, several proteins
found in stones are considered to be passively adsorbed,1 Deceased, October 1998
whereas others seem to play an active role in stone for-Key words: albumin, crystallization, kidney stones, aggregation, lith-
iasis. mation [11–13]. Therefore, the presence or the propor-
tion of a given protein within the stone matrix cannot be
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studies [5, 7, 14–16], has never been considered impor- collected and concentrated in a concentrator cell (Model
8050; Amicon, Beverly, MA, USA) mounted with a YM3tant in terms of stone formation. Actually, most studies
have focused on the inhibition of crystal growth [17, 18], membrane (cut-off 3000 Da; Amicon, Beverly, MA,
USA). Characterization of each peak was performed byand albumin has never been described as an inhibitor
of CaOx crystal growth. sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and nondenaturating PAGE.However, events governing the early steps of crystal
formation, that is, crystal nucleation, might also be im- Calcium oxalate nucleation by albumin coupled to
polystyrene plates. Samples of monomeric or polymericportant. Generation of a crystal can occur by homoge-
neous nucleation when local supersaturation allows albumin were prepared at 12.5 mg/ml in phosphate-buf-
fered saline (PBS) buffer. Control samples containedspontaneous organization of the atoms into the appro-
priate lattice. However, heterogeneous nucleation is only PBS. Maleic anhydride-activated 96-well polysty-
rene plates (Pierce, Rockford, IL, USA) were coatedmore likely to occur in complex mixtures such as urine,
where organic molecules, especially peculiar proteins, overnight at 378C with albumin samples (100 ml per well).
Noncoated protein was removed, and the wells weremay provide ionic patterns on their surface that promote
formation of the initial crystal lattice. washed three times with distilled water. The plates were
then incubated with a metastable solution of CaOx buf-Because albumin that is present in CaOx stones is one
of the most abundant proteins in urine and was shown fered at pH 7.0 or pH 4.0 for 48 hours at 378C. The
metastable solution was prepared by gently mixing (vol/to bind tightly to CaOx crystals in an ionic environment
similar to urine [15], we hypothesized that it could be vol) a solution containing 0.833 mm CaCl2, 150 mm NaCl
(pH 4.0 or pH 7.0) with a solution containing 0.167 mminvolved in CaOx crystal nucleation in urine. This
was tested in vitro by monitoring the effect of albumin sodium oxalate, 150 mm NaCl (pH 4.0 or pH 7.0). These
preparations were filtered through 0.22 mm membraneson crystal formation from metastable CaOx solutions.
Relevance to urinary lithogenesis was investigated by and kept at room temperature for several days without
the precipitation of salts. The appearance of crystalscomparing the nucleating activities of albumin purified
from urine of idiopathic calcium stone formers (ICSFs) was observed by light microscopy performed with an
Orthomat microscope (Leitz, Wetzlar, Germany) atand HS.
magnifications of up to 3150, and their composition was
confirmed by x-ray microprobe analysis (not shown).
METHODS
Calcium oxalate nucleation by albumin coupled to
Experiments involving serum albumin CNBr-sepharose beads. Monomers or polymers of com-
mercial albumin (10 mg/ml) were attached to the beadsHuman serum albumin (HSA) was obtained from the
Institut Me´rieux (Lyon, France) and was extensively dia- following the recommendations of the supplier (Phar-
macia, Uppsala, Sweden). Noncoated protein was re-lyzed against distilled water before use.
Quasi-elastic light scattering experiments. Quasi-elastic moved by extensive washings. The efficiency of coupling
was approximately 50%. The beads were incubated withlight-scattering (QELS) experiment measurements were
performed with a 5 W argon-ion laser (Model 2017; Spec- the same metastable solution of CaOx as discussed ear-
lier here, at pH 7, for 48 hours at 378C with constanttra Physics, Mountain View, CA, USA) and a SEM 633
goniometer coupled to a real-time correlator RTG (Sema- stirring. The solutions were then filtered, the beads re-
covered, dried, and directly used for scanning electrontech, Nice, France). Albumin samples (300 ml) were equili-
brated in water, filtered through a 0.5 mm membrane microscopy analysis, carried out using a Jeol 35C micro-
scope, operated at 25 kV. Sepharose beads were(LCR Millex, Millipore, Bedford, MA, USA), and placed
in a 12 mm diameter cylindrical glass cuvette. The cuvette mounted on metal stubs, coated with a thin gold layer
of approximately 600 to 800 A˚ by ion sputting. Thewas immersed in an 80 mm diameter index-matching
bath filled with 0.22 mm filtered methaxylene and ther- resolution was 60 A˚. The micrographs were produced
by secondary electrons. Sepharose beads were observedmostated at 378C. The power of the laser ranged from
50 to 500 mW, depending on albumin concentration. The at magnifications of up to 31500. The crystal composi-
tion was confirmed by x-ray microprobe analysis (notscatching angle was 908, and the sampling time was 1 ms.
High-performance liquid chromatography (HPLC). shown).
Kinetics of calcium oxalate crystallization in solution.Monomers and polymers of albumin were purified on a
gel filtration column (TSK G2000SW; Toyo-Soda, Tokyo, Calcium oxalate crystallization kinetics were determined
as previously described [19] by monitoring the increaseJapan) connected to an HPLC (Gold System; Beckman,
Palo Alto, CA, USA) using a 20 mm Tris-Cl, 150 mm in turbidity after mixing solutions of CaCl2 and NaOx
to generate a supersaturated CaOx solution. Briefly, anNaCl, pH 6, buffer. The flow rate was adjusted to 0.5
ml/min, and the absorbance was measured at 280 nm. 8 mm CaCl2 solution was placed into a light-path cuvette
within a spectrophotometer (Uvikon 930; Kontron In-Fractions corresponding to the two main peaks were
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struments, Munchen, Germany) at constant temperature 0.1 m glycine, pH 2.8, and neutralized by the addition of
1 m Tris, pH 9.5. The fractions containing the protein(308C) and constant stirring (500 rpm). Once the absorp-
tion baseline was reached, an equal volume of 1 mm were pooled and extensively dialyzed against distilled
water, lyophilized, and resuspended in 2 ml of distilledsodium oxalate solution was added, and OD620 (turbidity)
was recorded every three seconds. In these conditions, water. Protein estimation was performed with the BCA
Protein Assay (Pierce). The purity of albumin prepara-OD620 was directly proportional to the mass of crystals
formed per volume unit [20, 21]. To estimate the influ- tions was checked by two independent methods: (a) SDS-
PAGE followed by transfer onto nylon membranes andence of albumin on CaOx crystal formation, monomeric
or polymeric albumin purified by HPLC was added to immunodetection with antihuman albumin antibodies,
and (b) mass spectrometry where all fragments werethe CaCl2 solution at concentrations between 5 and 100
mg/ml before mixing with sodium oxalate. The slopes of assigned to albumin (not shown).
Calcium oxalate crystal nucleation by urinary albumin.the increases in OD620 were recorded and compared with
the slopes obtained in the absence of albumin. Polystyrene plates were coated with albumin purified
from urine of HS or idiopathic CaOx stone formers in
Experiments involving albumin purified the conditions described earlier here for commercial al-
from human urine bumin (12.5 mg/ml, 100 ml per well). Micrographs of the
bottoms of the wells were taken after 48 hours of incuba-Urine collection. Twelve ICSFs from our clinics (11
males, 1 female, mean age 6 sd, 41.9 6 11.8 years) were tion at 378C with the same metastable solution of CaOx
as discussed earlier in this article. Four pictures wererandomly chosen and gave their informed consent to
participate in the study. At the time of evaluation, 11 taken per well, at determined positions in the wells to
account for possible anisotropy near the well edges. Pic-had a low 24-hour urine output (less than 1500 ml) and
6 had idiopathic hypercalciuria (more than 0.1 mmol/kg/ tures were coded, and the number of CaOx crystals was
independently assessed by two investigators, whoseday). They had suffered from at least one calcium stone
passage during the last three years. A complete medical countings showed less than 2% discrepancy. Experi-
ments were made in triplicate. Human IgGs, H2O, andevaluation was done as previously described [22], which
eliminated an identifiable cause for their calcium-stone commercial albumin were used as controls.
disease, with the exception of low urine output and the
Detection of calcium oxalate crystals in urinefact that six of them showed idiopathic hypercalciuria.
They received no medication. Twelve HS were selected Twenty-four hour urine collections were obtained
from 579 consecutive patients with recurrent idiopathicas controls from laboratory staff (10 males, 2 females,
mean age 6 sd, 38.67 6 10.16 years). They had no per- CaOx lithiasis and from 156 HS. After homogenization
of the urine collections, 10 to 20 ml were withdrawn andsonal or familial history of urinary lithiasis or other renal
disease. All subjects were on a free diet when urine was placed onto a Malassez cell. The presence and nature of
crystals (CaOx monohydrate, dihydrate, or mixed) werecollected for 24 hours on sodium azide (0.02%).
Quantitation and purification of urinary albumin. The checked by polarization microscopy (Optiphot 2; Nikon,
Tokyo, Japan).urine pools were filtered on 0.8 mm membranes and
concentrated 20 to 30 times (to about 60 ml) by ultrafil-
Statistical analysistration with an artificial kidney (Altra Nova 140; Althin
Medical, Miami, FL, USA) fitted with a cellulose acetate Statistical analysis was performed using the SAS pack-
age (SAS Institute Inc., Cary, NC, USA). The tests usedfiber (cut-off, 3500). After extensive dialysis, concen-
trated urines were lyophilized, resuspended in 10 ml to evaluate the statistical significance of the differences
between groups of values are indicated in the text or inof water, and centrifuged at 5000 g. Supernatants were
frozen in liquid nitrogen and kept at –208C until use. Tables 2 and 3.
Albumin was assayed on 20 ml of concentrated urine
using a radial immunodiffusion assay (RID Albumin-
RESULTS
ML kit; The Binding Site, Birmingham, UK) following
Structure of albumin in solutionthe manufacturer’s instructions. An immunoaffinity col-
umn with anti-albumin antibodies (Nordic Immunologi- Quasi-elastic light scattering experiments conducted
on solutions of purified commercial albumin revealedcal Laboratories, Tilburg, The Netherlands) was pre-
pared with the AminoLink Immobilization Kit (Pierce) two populations of protein particles with diameters of
11.4 nm and around 200 nm (Fig. 1A). Crystallographicaccording to the supplier’s recommendations. The col-
umn was then loaded with the concentrated urine sam- data indicated that the former represented the monomer
(albumin M) and the latter represented a heterogeneousples from ICSFs and HS, previously equilibrated in PBS
buffer. The column was washed with five volumes of population consisting of aggregates (albumin P) [23, 24].
The monomer represented approximately 70% of totalPBS, 1 m NaCl. Albumin fractions were then eluted with
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Fig. 1. Size heterogeneity of albumin in solu-
tion. (A) Quasi-elastic light scattering (QELS)
pattern. The average results, expressed by the
gaussian curve (- - -), are diffusion coefficient
(cm2/second), 3.745E-7; mean diameter (nm),
1.144E11 6 1.493E10; and the polydispersity
2.172E-1 6 2.849E-2. (B) High pressure liquid
chromatography (HPLC) profile. Albumin was
submitted to gel filtration (TSK G2000SW;
Toyo-Soda) using 20 mm Tris-Cl (pH 6) and
150 mm NaCl. Fractions corresponding to mo-
nomers and polymers were collected, concen-
trated, and characterized by nondenaturing
(C) or SDS-PAGE (D).
albumin, whereas the polymer accounted for 30%. When by turbidimetry (Fig. 2). In the absence of albumin, the
absorbance at 620 nm, which reflects the presence of crys-albumin was subjected to HPLC fractionation by gel
filtration (Fig. 1B), it resolved as two peaks. The first tallized CaOx, increased spontaneously because of ho-
mogeneous nucleation. It increased faster in the presenceone, corresponding to the monomer, accounted for 95%
of the total. The second one was mostly dimeric albumin, of albumin M (Fig. 2A) or albumin P (heterogeneous
nucleation; Fig. 2B), showing that both could promoteand some of the albumin polymers were too large to
flow through the column (Fig. 1D). Nondenaturating crystal formation in solution. However, the nucleating
efficacies of the two forms of albumin could not be distin-gel electrophoresis (Fig. 1C) confirmed the existence of
dimers in albumin P, which did not totally disappear in guished by that method because crystal growth, resulting
from calcium and oxalate deposition onto newly formedSDS-PAGE (Fig. 1D), suggesting that the binding could
be very strong and possibly covalent. Such aggregates nuclei, also contributed to increased turbidity.
were also observed with albumin purified from urine
Calcium oxalate crystal nucleation by albumin(discussed later in this article).
Because formation of a crystal begins with a single
Promotion of calcium oxalate crystal formation in nucleation step, the nucleating activity of a molecule will
solution by albumin be best evaluated by the number of crystals that a given
amount of the molecule will promote. This is technicallyPromotion by albumin M and albumin P of CaOx crystal
formation from a supersaturated solution was monitored difficult to perform in solution. To assess the nucleating
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b
Fig. 2. Promotion of calcium oxalate (CaOx) crystal formation by albu-
min. Formation and growth of CaOx crystal from a supersaturated
solution was monitored by increased turbidity (absorbance at 620 nm).
The slope of the linear portion of the curve was determined during the
time interval when the correlation coefficient of the curve, r2, exceeds
0.99. The slopes of increased absorbance were calculated in the absence
of albumin (control) and in the presence of various concentrations of
monomeric (A; j) or polymeric (B; h) albumin. For each concentration
of albumin, the percentage of promotion relative to control was ex-
pressed as [(Tsp/Tsc) – 1] 3100, where Tsc is the turbidity slope of control
and Tsp the turbidity slope in the presence of monomeric (HSA-M) or
polymeric (HSA-P) albumin (N 5 6).
were used as a control. In the absence of albumin, only
a few crystals appeared, due to local foci of supersatura-
tion, which promote homogeneous nucleation. They
showed the birefringent hexagonal platelets typical of
CaOx monohydrate (COM) crystals. In the presence of
albumin, nonbirefringent octahedral bipyramids typical
of CaOx dihydrate (COD) were observed [25, 26]. Many
spicules of crystals appeared with albumin M, and more
numerous crystallization foci were observed with albu-
min P. Crystals grew until they covered the field of view.
This is explained by the fact that once nucleation has
taken place, crystals grow very quickly by accretion of
new layers. Accretion stops when the concentration of
calcium or oxalate has reached the threshold of solubil-
ity. The influence of albumin conformation on nucleation
was evaluated by performing the same experiments at
pH 4.0. Although the ability of CaOx to crystallize is
not affected by pH, albumin conformation changes with
pH [27] and should be modified when shifting the pH
from 7.0 to 4.0 because its pI is around 5.0. Nucleation
by albumin was indeed suppressed at pH 4.0, whereas
homogeneous nucleation was unchanged (Fig. 3).
Analysis with albumin coated onto plates allowed the
observation of large fields, but close examination of the
crystals was difficult. To have a better look at crystal
structures, we used albumin coated onto sepharose beads
(Fig. 4). Noncoated beads showed no crystallization on
their surface. Conversely, beads coated with albumin M
confirmed the presence of the opaque diamond-shaped,
square-pyramidal structure typical of COD crystals. This
was actually checked by powder diffraction pattern ob-
tained by transmission electron microscopy (JEOL 2000
FX; not shown). The spike-like structures were typical
of heterogeneous nucleation. We observed many more
CaOx crystals on beads coated with albumin P. They
formed larger dendritic aggregations than with albumin
M. Scanning electron microscopy confirmed that crystals
nucleated by polymers were larger than those nucleated
by monomers, which underscores the importance of pro-
activity of albumin, polystyrene wells were coated with tein aggregation in the nucleation process.
albumin monomers or polymers filled with a metastable
Visible calcium oxalate crystalline forms in urineCaOx solution at pH 7.0. Crystal formation at the bottom
of the wells was monitored, and crystal morphology was Urine from 156 HS and 579 stone formers was ana-
lyzed for presence of visible CaOx crystals (above 1 mm)analyzed by optical microscopy (Fig. 3). Uncoated wells
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Fig. 3. Albumin-induced nucleation of CaOx crystals on polystyrene plates. Pictures show representative fields of polystyrene wells in which CaOx
crystals were allowed to form for 48 hours from a metastable solution. Wells were coated with monomeric albumin (HSA-M) or polymeric albumin
(HSA-P). Control wells (C) were uncoated. In the presence of albumin, crystals show the typical structure of calcium oxalate dihydrate (magnification
3150).
by optical microscopy. Crystals could be observed in the number of crystals that eventually formed. As a con-
trol, wells of the same plate were coated with commercial14.1% of HS and 42.7% of stone formers. Proportions
among crystal forms (COM, COD, and mixed COM/ albumin or human IgGs at the same concentrations or
were left uncoated. As shown in Table 2, albumin puri-COD) are given in Table 1. COD was the most abundant
form in HS (86.4%) and stone formers (78.1%). Mixed fied from the urine of HS induced significant nucleation
COM/COD crystals, in which the content in COM was of CaOx crystals, generating five times more crystals
low (1.9%), were present in similar proportions in the compared with spontaneous (homogeneous) nucleation.
two populations. However, COM crystals were never IgGs had no effect. Urinary albumin was a more potent
observed in HS. nucleator than commercial serum albumin.
Albumin in urine of idiopathic calcium stone formers Calcium oxalate crystal nucleation by urinary albumin
and healthy subjects As discussed earlier in this article, nucleation was eval-
The volumes of the 24-hour urine collections were uated by the number of crystals generated from a meta-
significantly larger in ICSFs than in HS (1892 6 637 ml stable CaOx solution in wells coated with albumin. Iden-
vs. 1392 6 503 ml, mean 6 sd; N 5 12, P 5 0.044). This tical amounts of albumin prepared from urine of 12 HS
was expected because stone formers had been advised and 12 ICSFs were used for coating three wells each,
to drink more water. However, albumin excretion per and the experiment was done twice. Using an indirect
24 hours was not different in ICSFs (2.66 6 1.53 mg/ enzyme-linked immunosorbent assay (ELISA) tech-
24 hr) and HS (2.40 6 1.22 mg/24 hr). The distribution nique, we showed that the amount of albumin coated
of value was wide (0.192 to 21.78 mg/24 hr), in agreement was similar in ICSFs and HS. This was done by coating
with previous data from Hemmingsen and Skaarup [28]. the wells with progressive dilutions of albumin and quan-
titating the actual amount of protein attached by ELISA
Induction of CaOx nucleation by albumin purified (not shown). As shown in Table 3, CaOx crystals induced
from urine by albumin from HS were significantly more numerous
than with albumin from idiopathic calcium-stone for-Nucleation was evaluated by coating polystyrene wells
with albumin purified from the urine of HS, placing a mers. In the two experiments, the number of crystals
was 20 and 45% higher in HS than in ICSFs, respectively.metastable solution of CaOx into the wells, and counting
Cerini et al: Albumin promotes CaOx crystallization1782
Table 1. Percentage of COM, COD and mixed COM/COD among
CaOx crystals in urine of healthy subjects and stone formers
Healthy subjects Stone formersVisible crystalline
forms of CaOxa %
COD 86.4 78.1
COM 0 6.1
COD/COM 13.6 15.8
Analysis of urine from healthy subjects (N 5 156) and stone formers (N 5
579) showed the presence of CaOx crystals in 14.1% of healthy subjects (N 5
22) and 42.7% of stone formers (N 5 247). The number of CaOx crystals per
volume unit was determined, each crystal was characterized as calcium oxalate
dihydrate (COD), calcium oxalate monohydrate (COM) or mixed (COD/COM),
and the respective percentages of the three crystalline forms are provided.
a Crystals above 1mm (optical threshold)
Table 2. Induction of CaOx crystallization in vitro by albumin
purified from human urine
Commercial
Albumin from HS albumin H2O IgGs
277.676148.33 100.67 639.15 52.20631.27 36.60623.95
CaOx crystals were allowed to form from a metastable solution, in polystyrene
wells. Wells had been coated with albumin purified from urine of healthy subjects
(HS, N 5 10), with commercial albumin (N 5 6) or with IgGs (N 5 6) to control
heterogeneous nucleation. Background nucleation was estimated from uncoated
wells H2O, N 5 10). Crystals formed were counted on pictures of fields taken
in selected positions in the wells (see Methods section). Results are given as
average number of crystals per field 6 sd. Urinary albumin induced formation of
significantly more crystals than commercial albumin or IgGs (P , 0.05). Statistical
significance was calculated by the ANOVA test.
Table 3. Induction of CaOx crystal nucleation by urinary albumin
Number of CaOx crystals per surface unit
Albumin from
idiopathic calcium Albumin from
Experiment Control stone-formers healthy subjects P
1 2165.1 113.4627.9 166.2657.7 0.034
2 562 36.468.0 43.467.8 0.041
Polystyrene wells were coated with urinary albumin from healthy subjects
(N 5 12) or stone-formers (N 5 12), filled with a metastable solution of CaOx and
crystals allowed to form for 48 hours. In the control experiments, homogeneous
nucleation was estimated from uncoated wells (H2O, N 5 6). The number of
CaOx crystals observed per surface unit was recorded as indicated in the Methods
section. Results are expressed as mean 6 sd. Statistical significance of the differ-
ences between crystal numbers in stone formers and healthy subjects was calcu-
lated by the Kruskal-Wallis non-parametric test.
Fig. 4. Albumin-induced nucleation of CaOx crystals on CNBr-sepha- Table 4. Distribution of aggregated forms of urinary albumin
rose beads. CaOx crystals were allowed to form for 48 hours in a purified from idiopathic calcium stone-formers (ICSF, N 5 12)
metastable solution, in wells containing sepharose beads to which and healthy subjects (HS, N 5 12)
was coupled monomeric albumin (HSA-M) or polymeric albumin
(HSA-P). Uncoupled beads were used as control (C). Scanning electron Monomers,
microscopy pictures of beads are shown. CaOx crystals are present on Albumin Monomers Monomers Dimers and
coated beads, with typical square pyramidal structures. More crystal aggregation Monomers and Dimers and Polymers Polymers
aggregation is visible on beads coated with HSA-P.
ICSF 6 5 0 1
HS 0 0 4 8
The presence of monomers, dimers and polymers was assessed upon resolution
of albumin samples on SDS-PAGE. Statistical significance of the difference
Aggregated forms of albumin in urine in the distribution of albumin forms was calculated by the Fisher’s exact test
(P , 0.00001).Albumin purified from urine of the 12 patients and
12 controls was analyzed by SDS-PAGE. Monomeric
albumin (67 kDa) was observed in all samples. Dimers one stone-former, whereas the dimer was present in eight
HS and five stone formers. The albumin patterns from(approximately 130 kDa) and polymers (300 kDa or
more) were observed more frequently in HS than in a healthy subject showing the dimer and the polymers
and from a stone former showing the monomer only arestone formers (P , 0.00001). Distributions are given in
Table 4. The polymers were found in all HS but in only shown on Figure 5.
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DISCUSSION
It is well known that several macromolecules, even
described as inhibitors of crystallization, when immobi-
lized to a surface, can act as promoters of crystal forma-
tion [29]. However, the most important finding from this
study is that albumin is an efficient promoter of CaOx
crystal nucleation in vitro, not only bound to a solid
phase but also in solution. These results constitute an
extension of the work of Kavanagh’s group [30, 31],
who used a mixed suspension, mixed product removal
continuous crystallization technique to show that the
CaOx crystal nucleation rates were significantly higher
in urine from HS than in urine from recurrent stone
formers. Furthermore, they showed that crystalluria was
lower in the urine of stone formers. Hence, because urine
is saturated in CaOx and albumin is one of the most
abundant urinary proteins, it is likely that albumin will
promote CaOx crystal formation in urine. Earlier work
showed that crystallization can occur in the primary
urine, that is, in the proximal tubule where part of the
albumin is filtered and even in the glomerular capsule
[32, 33], indicating that albumin molecules are more
likely to promote CaOx nucleation in ducts. At first
sight, such activity regarding lithiasis could be considered
detrimental because one could assume that keeping the
number of CaOx crystals formed in primitive urine to a
minimum would facilitate the control of their growth by
specific inhibitors. Actually, increasing the number of
crystal nuclei would be beneficial because it would de-
crease CaOx saturation, thereby limiting the size that
crystals could reach and favoring their elimination by
the urine flow [34]. The fact that healthy subjects have
significantly smaller crystals in their urine than stone Fig. 5. SDS-PAGE analysis of albumin purified from human urine.
Albumin was purified from urine of idiopathic calcium stone formersformers supports this hypothesis [31, 35–39].
and healthy subjects as described in the Methods section. The pictureExperiments showing CaOx nucleation by serum albu- shows the patterns on SDS-PAGE of samples from albumin purified
min had to be controlled with urinary albumin to assess from a representative healthy subject (lane 2) and a representative
stone-former (lane 3). Lane 1 shows molecular weight markers (LMW;their relevance to urinary lithiasis. Albumin purified by
Pharmacia). Positions of albumin monomers (M), dimers (D), andimmunoaffinity from the urine of HS did promote CaOx polymers (P) are indicated to the right. The molecular weights (in
nucleation, and its specific activity was higher than that kDa) of markers are indicated on the left.
of commercial serum albumin. Such a difference could
hardly be explained by differences in the primary struc-
ture of the protein, although secondary modifications
of this process has been described. HSA possesses 17such as glycation [40] could not be excluded. We exam-
disulfide bridges. The remaining Cys34-SH is free. Thisined whether or not oligomerization of albumin could
form of albumin monomer, named mercaptalbumin (re-be involved, because the capacity of albumin to form
duced form), is highly reactive and could be oxydizedaggregates is well known [27, 41, 42], and other proteins
(nonmercaptalbumin form) in urine by a reaction withwith crystal-nucleating properties are much more active
several ligands as a covalent carrier protein. When itwhen aggregated [43]. QELS experiments conducted on
reacts with other monomers, it is responsible for apurified serum albumin confirmed that the protein in so-
major part of the covalent aggregation [41]. Therefore,lution was partly monomeric and partly aggregated (Fig.
blocking the free-SH group should prevent aggregation1A). Monomers and aggregates could induce CaOx nucle-
and irreversible conformational changes [44].ation, but the aggregates were much more efficient (Fig. 3).
Quasi-elastic light scattering experiments could not beAggregation of albumin has been studied for more
than 40 years. Thus far, however, no clear understanding used to analyze aggregation of urinary albumin because
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the amounts of protein required by that technique are et al, who showed that, in CaOx stones, COM and COD
formed distinctive separate layers, with COD alwaystoo large. Indirect information was obtained by submit-
ting urinary albumin to SDS-PAGE. Polymers could be found in the outer layers and COM in the center [58].
Hence, the buildup of stones from crystals would primar-evidenced, even in such strong denaturing conditions,
suggesting that the polymers detected by this technique ily be due to the aggregation of COM crystals, suggesting
that crystals generated by albumin nucleation would lessare covalent. Therefore, HSA from urine is a mixture
of reduced and oxydized forms that produces various likely evolve toward stones. However, despite finding
that albumin was always associated with urinary stonessizes of aggregates in significant amounts.
The extent of albumin polymerization in urine from [5, 7, 14, 15], we urge cautiousness when extrapolating
results obtained in vitro to the more complex environ-HS and stone formers could be compared because the
12 samples obtained for each group were purified by the ment of primitive urine. Albumin-containing COD crys-
tals could aggregate onto COM crystals, or free albuminsame procedure. Individual variations in the electropho-
retic patterns on SDS gels were observed in each group. could adsorb on the surface of crystals already formed,
as shown by Edyvane, Ryall and Marshall, who demon-However, polymers were significantly more frequent in
albumin from HS than from ICSF (Table 4 and Fig. 5). strated that it inhibited CaOx crystal aggregation [59].
A better knowledge of the molecular mechanism of albu-Because polymers are better nucleators than monomers,
urinary albumin from HS was expected to show stronger min interaction with crystals is required in order to un-
derstand its role in the control of lithogenesis.crystal promoting activity than albumin from ICSFs,
which is indeed what we observed (Table 3). Most of Initiation of crystal nucleation implies that the nuclea-
tor provides an adequate template for the respectivethe time, the oxidized form was predominant in various
diseases such as non-insulin-dependent diabetes mellitus positioning of the ions forming the first crystal lattice.
We have shown that not all proteins, even large ones[45] or even in the elderly with the formation of advanced
glycation end (AGE) products [46, 47]. Consequently, like IgGs, can promote nucleation. The structure of the
potential nucleator in solution is the determinant. Stud-in this situation, the formation of polymers and their size
are considerably reduced [48]. This is actually what we ies on ice-nucleating proteins from bacteria suggested
that a repetitive configuration was required to provideobserved in ICSF patients, and that is why we do not
think that a genetic disorder of the albumin gene could an appropriate template [43]. Albumin would fit that
requirement because crystallographic data show that itsbe responsible for this type of damage.
Although HSA has been detected in stone matrix, the structure comprises a repetitive series of three helical
homologous domains, with each domain being formedmechanism by which it is included is not known. One
can therefore suspect HSA to be involved in aggregation by two smaller subdomains [23, 24]. Calcium ions can
bind albumin through carbonyl or carboxyl groups. Con-of CaOx crystals leading to the formation of stones.
However, this is not the case because it has been shown trary to what occurs with most Ca21-binding proteins
[60], carboxyl groups seem preferentially involved in thethat albumin reduces the size of crystal aggregation [49]
in a concentration-dependent manner [50]. Recently, this nucleation of CaOx with albumin, because the strong
nucleation observed at pH 7 was totally abolished at a pHreduction has been measured at 32% of the initial value
(5.9 vs. 8.6 nm) [51]. Therefore, these results suggest of 4, when the carboxyl groups were no longer ionized.
Because CaOx crystals present with faces composed ofthat the appropriate promotion of CaOx nucleation by
albumin is required to avoid stone formation. alternate layers of calcium and oxalate ions, we propose
that, by diffusion and adsorption of calcium over theAnother observation supporting a beneficial role for
albumin nucleation of CaOx was that crystals formed in protein surface, albumin could stabilize calcium interac-
tions by ionotropic effect and initiate crystal nucleationthese conditions were CaOx dihydrate, which is thermo-
dynamically less stable than CaOx monohydrate (Figs. by ion pairing, allowing binding to oxalate ions [61]. This
is in agreement with morphological features of COD3 and 4). Analysis of CaOx crystal composition in urine
demonstrated that crystals containing only COM were crystals that form on polystyrene plates: crystals lie on
the plane perpendicular to the tetragonal axis, which isfound in stone formers but never in HS (Table 1), al-
though the urine had a similar level of CaOx saturation rich in calcium in the dihydrate structure (pH 7, HSA-M;
Fig. 3). A similar mechanism was suggested by Perl-in both groups [52–54]. Several recent independent stud-
ies, for example, from Brien, Schubert and Brick in Ger- Treves and Addadi for sodium urate, in which the nucle-
ation by albumin takes place by sodium binding [62].many on 10,000 stones [55], Mandel and Mandel in the
USA [56], and Daudon et al in France who analyzed The capacity of albumin to induce crystal nucleation of
CaOx and sodium urate, in which the molecular struc-10,617 calculi [57], have unambiguously demonstrated
that COM is the most common constituent found in tures are different, suggests that albumin might also in-
teract with other salts to which it was found to be associ-calculi (approximately 44% of COM vs. 23% of COD
for the last study). The association between COM and ated, such as calcium phosphate in tooth enamel [63]
and calcium carbonate in gallstones [64]. That mecha-the occurrence of lithiasis were also suggested by Iwata
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nism might also be extended to other molecules than Professor Boistelle will remain, for the international com-
munity of crystallographists, a distinguished example ofcalcium salts, as albumin was equally abundant in urinary
scientific excellence and kindness.stones made up of uric acid and cystine [15].
Altogether, these results suggest that the control of
Reprint requests to Jean-Michel Verdier, UPRESA-CNRS 6032,
urinary lithogenesis might not be exerted only by inhibi- Faculte´ de Pharmacie 27, Bd Jean Moulin, 13385 Marseille Cedex 05,
France.tors of crystal growth. Albumin, and possibly other pro-
E-mail: verdier@marseille.inserm.frmoters, would also be involved by a different way. They
would facilitate the elimination of CaOx crystals by in-
ducing the formation of numerous crystals that would APPENDIX
remain small enough to be easily eliminated, and among Abbreviations used in this article are: albumin-M or HSA-M, mono-
meric albumin; albumin-P or HSA-P, polymeric forms of albumin;them, albumin would favor the formation of COD, which
CaOx, calcium oxalate; COD, calcium oxalate dihydrate; COM, cal-is less associated with urinary stone buildup (M. Daudon,
cium oxalate monohydrate; HS, healthy subjects; HSA, human serum
unpublished observations). The occurrence of stones prob- albumin; ICSFs, idiopathic calcium stone-formers; QELS, quasi-elastic
light scattering; SDS-PAGE, sodium dodecyl sulfate-polyacrylamideably results from the conjunction of several mechanisms,
gel electrophoresis; SEM, scanning electron microscopy.including a defect in crystal growth control, but also
crystal aggregation and crystal retention by adsorption
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